Pharmanovia is a global specialty pharmaceutical company. We partner with innovative biotech and large pharma to bring innovative specialty medicines to patients, while supporting trusted established brands across more than 160 markets.
More about us
We are experts in bringing specialty medicines to market to deliver better patient outcomes for tomorrow.
We manage a broad portfolio of trusted established brands which provide important patient treatment options today.
We select and advance assets based on clear scientific rationale, patient need and portfolio symmetry.
Offices
Active presence in more than 160 markets globally
A global team of more than 300 specialists
Company transactions
Trusted established and specialty medicine brands
Strong track record acquiring and managing pharmaceutical assets
Experienced partner for licensing and commercialisation
NCEs
As of 27/4/26
Partnership is at the heart of everything we do. Working with biotech innovators and leading pharmaceutical companies, we bring important medicines to patients around the world. Our model blends central expertise with local insight, enabling successful launches, dependable supply, and stronger in-market performance across specialty assets and established brands alike.
We believe people power performance. Our values define how we make decisions, build trust and deliver results, they make Pharmanovia more than a place to work, they make it a place where talented people can make a difference and build purposeful careers.
FOR IMMEDIATE RELEASE – BASILDON, UK, 17 JUNE 2026 Pharmanovia, a global specialty pharmaceutical company, has...
More informationPRESS RELEASE – FOR TRADE AND BUSINESS MEDIA ONLY PHARMANOVIA ANNOUNCES LAUNCH OF KORJUNY (CATUMAXOMAB) IN...
More informationFor immediate release, 1st October 2025, Basildon, UK: Pharmanovia today announced the appointment of Stephan Eder as...
More information
German site
